Sierra Leone vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Sierra Leone
100.0%
in 2024
Tajikistan
100.0%
in 2024
Sierra Leone rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sierra Leone
- Tajikistan
How they compare
Sierra Leone currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 4 times across 15 shared years of data; in 2009 it was Tajikistan ahead.
Sierra Leone ranks 1st and Tajikistan ranks 1st of 144 countries.
Across the 3 decades both report, Sierra Leone averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Sierra Leone | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 45.0% | 32.0% | Tajikistan |
| 2010s | 69.4% | 74.2% | 4.8% | Tajikistan |
| 2020s | 100.0% | 97.8% | 2.2% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sierra Leone or Tajikistan?
- Sierra Leone, at 100.0% against 100.0% in Tajikistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sierra Leone and Tajikistan?
- 0.0%, with Sierra Leone ahead.
- How many years of comparable data are there for Sierra Leone and Tajikistan?
- 15 years are reported by both, from 2009 to 2024.
- How do Sierra Leone and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sierra Leone ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.